A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects

NCT00902681 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment of Overactive Bladder

Interventions

DRUG: Fesoterodine
DRUG: Fesoterodine

Sponsor

Pfizer